Herve de Kergrohen, M.D., was named CEO and director of Anavex Life Sciences Corp., a Geneva, Switzerland, company that develops drugs for the treatment of cancer and neurological diseases. De Kergrohen for the past several years was a partner in the life sciences division of Paris-based venture capital firm CDC Innovation. In 2007 and 2008, he was CEO of Praxim, which develops and sells equipment for robotic orthopedic surgery.
De Kergrohen named CEO of Swiss drugmaker
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.